Summary measure of discrimination in survival models based on cumulative/dynamic time-dependent ROC curves

Statistical Methods in Medical Research

Volumn 25, Issue 5, 2016, Pages 2088-2102

  Lambert, Jérôme ^a,c   Chevret, Sylvie ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

discriminative performances; prognosis; receiver operating characteristics curve; survival models

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; AREA UNDER THE CURVE; ARTICLE; BOOTSTRAPPING; CANCER SURVIVAL; COMPENSATED LIVER CIRRHOSIS; CONFIDENCE INTERVAL; EVENT FREE SURVIVAL; HUMAN; MATHEMATICAL VARIABLE; MONTE CARLO METHOD; MORTALITY; MULTICENTER STUDY (TOPIC); NONPARAMETRIC TEST; OVERALL SURVIVAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; SIMULATION; SURVIVAL ANALYSIS; SURVIVAL PREDICTION; SURVIVAL TIME; TIME; ACUTE MYELOID LEUKEMIA; DISEASE FREE SURVIVAL; FIBROSIS; PROBABILITY; TIME FACTOR;

AREA UNDER CURVE; DISEASE-FREE SURVIVAL; FIBROSIS; HUMANS; LEUKEMIA, MYELOID, ACUTE; PROBABILITY; PROGNOSIS; ROC CURVE; TIME FACTORS;

EID: 84989841716     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280213515571     Document Type: Article

References (30)

1. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: A framework for traditional and novel measures. Epidemiology 2010; 21 (1): 128-138.
2. Harrell FE Jr, Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA 1982; 247 (18): 2543-2546.
3. Pepe MS, Janes H, Longton G, et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004; 159 (9): 882-890.
4. Heagerty PJ, Lumley T, Pepe MS,. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000; 56 (2): 337-344.
5. Heagerty PJ, Zheng Y,. Survival model predictive accuracy and ROC curves. Biometrics 2005; 61 (1): 92-105.
6. Blanche P, Latouche A and Viallon V. Time-dependent AUC in the presence of censored data: A survey study. arXiv preprint arXiv:1210.6805, 2012.
7. Cai T, Pepe MS, Zheng Y, et al. The sensitivity and specificity of markers for event times. Biostatistics 2006; 7 (2): 182-197.
8. Etzioni R, Pepe M, Longton G, et al. Incorporating the time dimension in receiver operating characteristic curves: A case study of prostate cancer. Med Decis Making 1999; 19 (3): 242-251.
9. Slate EH, Turnbull BW,. Statistical models for longitudinal biomarkers of disease onset. Stat Med 2000; 19 (4): 617-637.
10. Harrell FE Jr, Lee KL, Mark DB,. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15 (4): 361-387.
11. Pencina MJ, D'Agostino RB,. Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation. Stat Med 2004; 23 (13): 2109-2123.
12. Uno H, Cai T, Pencina MJ, et al. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med 2011; 30 (10): 1105-1117.
13. Blanche P, Dartigues JF, Jacqmin-Gadda H,. Review and comparison of ROC curve estimators for a time-dependent outcome with marker-dependent censoring. Biom J 2013; 55 (5): 687-704.
14. Li J, Ma S,. Time-dependent ROC analysis under diverse censoring patterns. Stat Med 2011; 30 (11): 1266-1277.
15. Royston P, Parmar MK,. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Stat Med 2011; 30 (19): 2409-2421.
16. Hung H, Chiang C-T,. Estimation methods for time-dependent AUC models with survival data. Can J Stat 2010; 38 (1): 8-26.
17. Uno H, Cai T, Tian L, et al. Evaluating prediction rules for t-year survivors with censored regression models. J Am Stat Assoc 2007; 102 (478): 527-537.
18. Trinchet JC, Chaffaut C, Bourcier V, et al. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities. Hepatology 2011; 54 (6): 1987-1997.
19. Pautas C, Merabet F, Thomas X, et al. Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: Results of the ALFA-9801 study. J Clin Oncol 2010; 28 (5): 808-814.
20. Chambless LE, Diao G,. Estimation of time-dependent area under the ROC curve for long-term risk prediction. Stat Med 2006; 25 (20): 3474-3486.
21. Song X, Zhou X-H,. A semiparametric approach for the covariate specific ROC curve with survival outcome. Stat Sin 2008; 18 (3): 947-965.
22. Gelber RD, Gelman RS, Goldhirsch A,. A quality-of-life-oriented endpoint for comparing therapies. Biometrics 1989; 45 (3): 781-795.
23. Gönen M, Heller G,. Concordance probability and discriminatory power in proportional hazards regression. Biometrika 2005; 92 (4): 965-970.
24. Pepe MS, Kerr KF, Longton G, et al. Testing for improvement in prediction model performance. Stat Med 2013; 32 (9): 1467-1482.
25. Vickers AJ, Cronin AM, Begg CB,. One statistical test is sufficient for assessing new predictive markers. BMC Med Res Methodol 2011; 11: 13-13.
26. Zheng Y, Cai T, Feng Z,. Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers. Biometrics 2006; 62 (1): 279-287.
27. Zheng Y, Heagerty PJ,. Prospective accuracy for longitudinal markers. Biometrics 2007; 63 (2): 332-341.
28. Saha P, Heagerty PJ,. Time-dependent predictive accuracy in the presence of competing risks. Biometrics 2010; 66 (4): 999-1011.
29. Viallon V, Latouche A,. Discrimination measures for survival outcomes: Connection between the AUC and the predictiveness curve. Biom J 2011; 53 (2): 217-236.
30. Antolini L, Boracchi P, Biganzoli E,. A time-dependent discrimination index for survival data. Stat Med 2005; 24 (24): 3927-3944.